Annual funding for President Barack Obama’s brain research initiative would quadruple the current allocation under recommendations by advisers to the project, providing a $4.5 billion investment spread over the next decade.
Flying cars, meals in pill form, robot overlords — many attempts to predict the future turn out predictably wrong. Not so with a National Science Foundation study in 1982 that foresaw, with a prescience that feels like time travel, the rise of networked computing and its ensuing challenges to society.
In the old days, the U.S. program for foreign-student visas helped developing nations and brought diversity to then white-bread American campuses. Today, the F-1 program, as it is known, has become a profit center for universities and a wage-suppression tool for the technology industry.
President Barack Obama announced a U.S. campaign that may lead to new treatments for some of the least understood brain disorders, benefiting efforts by Pfizer Inc., Roche Holding AG and Eli Lilly & Co.
U.S. college presidents make no apologies for their schools’ support for research. After all, American institutions dominate global surveys of universities, and most lists put a big emphasis on research accomplishments.
Eli Lilly & Co. Chief Executive Officer John Lechleiter said during a panel discussion in Washington that U.S. lawmakers should renew the research-and- development tax credit to make it easier for companies to compete globally. The Oct. 5 event, sponsored by Harvard University and the Business Roundtable and hosted by Bloomberg News in Washington, centered on ways to spur innovation.